Intensity Therapeutics (INTS) Earnings Date & Reports

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

INTS is expected to report earnings to fall 9.11% to -87 cents per share on August 06

Intensity Therapeutics INTS Stock Earnings Reports

Q2'26

Est.

$-0.87

Q1'26

Missed

by $0.90

Q4'25

Missed

by $1.26

Q3'25

Est.

$-0.06

Q2'25

Beat

by $0.03

The last earnings report on May 07 showed earnings per share of -95 cents, missing the estimate of -5 cents. With 67.50K shares outstanding, the current market capitalization sits at 10.60M.

View a ticker or compare two or three

Compare

INTS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for INTS